A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 2 September 2024) has been published and includes articles on: Valproate use in men: as a precaution, men and their partners should use effective contraception Letters and medicine recalls sent to healthcare professionals in August 2024. To see the latest
Read more
MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Drug alert number: EL (24)A/43 Date issued: 26 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Risperidone 1mg
Read moreMore than 48,000 pharmacy opening hours were lost to temporary closures in England in 2023 – equivalent to around 5,800 working days – and more than 400 pharmacies closed permanently, new research from Healthwatch England has found. The Pharmacy closures in England briefing, published today (26th September), calls for greater support for pharmacy teams to
Read moreOn 28th August 2024, the Department of Health and Social Care (DHSC) published its response to the targeted consultation: ‘Medical Devices in Primary Care: Proposals for updating Part IX of the Drug Tariff‘. Part IX of the The Drug Tariff contains the appliances and chemical reagents, which can be prescribed by prescribing practitioners in primary care operating under NHS General Medical
Read moreCommunity Pharmacy England is back in Liverpool to engage new and returning Labour MPs at this year’s Labour Party Conference. This follows on from the Liberal Democrat Conference, which we attended last week and ahead of Conservative Party Conference, which we’ll attend next week. Community Pharmacy England Fringe Event This year, we partnered with the
Read moreCommunity Pharmacy England met earlier this month in London, with Members reviewing early engagement with the new Government, alongside the outlook for the Community Pharmacy Contractual Framework (CPCF) negotiations for 2024/25. During a meeting on 11th and 12th September 2024, Committee Members remained focused on the urgent challenges facing pharmacy owners, particularly the barriers to
Read moreAs announced in the NHS Primary Care bulletin (published 19 September 2024), from 1 January 2025, GP practices will be able to order the sub dermal contraceptive implant (Nexplanon® 68mg implant) directly from their suppliers and claim back the cost. This will mean that patients do not have to go to the pharmacy to pick
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Nicorandil 10mg tablets. MSN/2024/096 Tier 2 – medium impact Date of issue: 19th September 2024 There are limited supplies of nicorandil 10mg tablets until 30th September 2024. Nicorandil 20mg tablets remain available and can support increased demand. Alternative treatments for angina
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/09/2024) announced the following list of price concessions for September 2024: Drug Pack size Price concession Amiloride 5mg tablets 28 £15.94 Benzoyl peroxide 5% / Clindamycin 1% gel 30
Read moreMHRA Class 3 Medicines Recall: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd) Drug alert number: EL(24)A/42 Date issued: 18 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines defect information notice for: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd) Company name: Orion Pharma (UK) Ltd Product name: Eldepryl
Read more
